Weigang Tong
- Molecular Biology
- Pharmacology top 2%
- Oncology top 10%
- Cancer Research top 10%
- Genetics top 10%
- Co-authors
- Thomas E. AdrianXianzhong DingRichard C. WittRené HennigJens StandopParviz M. PourMarina TalamontiRichard H. Bell
- Topics
- Inflammatory mediators and NSAID effects (9 papers)Acute Myeloid Leukemia Research (6 papers)Cancer, Stress, Anesthesia, and Immune Response (5 papers)
- Cited by
- PharmacologyBiochemistryToxicology
- Journals
- BloodCancerCancer Research
- Partner nations
- United StatesGermany
In The Last Decade
Weigang Tong
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 632
- Pharmacology 451
- Oncology 270
- Cancer Research 198
- Genetics 194
Countries citing papers authored by Weigang Tong
This map shows the geographic impact of Weigang Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weigang Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weigang Tong more than expected).
Fields of papers citing papers by Weigang Tong
This network shows the impact of papers produced by Weigang Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weigang Tong. The network helps show where Weigang Tong may publish in the future.
Co-authorship network of co-authors of Weigang Tong
This figure shows the co-authorship network connecting the top 25 collaborators of Weigang Tong. A scholar is included among the top collaborators of Weigang Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weigang Tong. Weigang Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 0 | |
| 3 | 29 | |
| 4 | 58 | |
| 5 | 22 | |
| 6 | 24 | |
| 7 | 81 | |
| 8 | 2 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | The dual ABL/SRC inhibitors dasatinib, SKI-606, and INNO-406 are potent inhibitors of T cell acute lymphoblastic leukemia cell lines expressing the NUP214-ABL1 fusion kinase | 1 |
| 13 | 26 | |
| 14 | 98 | |
| 15 | 30 | |
| 16 | 39 | |
| 17 | 155 | |
| 18 | 73 | |
| 19 | 74 | |
| 20 | Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. | 108 |
About Weigang Tong
Weigang Tong is a scholar working on Hematology, Genetics and Pharmacology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Acute Myeloid Leukemia Research (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (5 papers). The work is most often cited by research in Pharmacology (451 citations), Biochemistry (142 citations) and Toxicology (54 citations). Weigang Tong has collaborated with scholars based in United States and Germany. Frequent co-authors include Thomas E. Adrian, Xianzhong Ding, Xianzhong Ding, Richard C. Witt, René Hennig, Jens Standop, Parviz M. Pour, Marina Talamonti, Richard H. Bell and Linheng Li. Their work appears in journals such as Blood, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.